These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25927868)

  • 1. Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.
    Ravelli A; Reuben JM; Lanza F; Anfossi S; Cappelletti MR; Zanotti L; Gobbi A; Milani M; Spada D; Pedrazzoli P; Martino M; Bottini A; Generali D;
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):689-702. PubMed ID: 25927868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
    Sanchez K; Page D; McArthur HL
    Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic approaches for the treatment of breast cancer.
    Knutson KL; Schiffman K; Rinn K; Disis ML
    J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):353-65. PubMed ID: 10705919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for the treatment of breast cancer.
    Ernst B; Anderson KS
    Curr Oncol Rep; 2015 Feb; 17(2):5. PubMed ID: 25677118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Blockade in Breast Cancer Therapy.
    Bu X; Yao Y; Li X
    Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Immunotherapy Strategies in Breast Cancer.
    Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer.
    Sivaganesh V; Promi N; Maher S; Peethambaran B
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging immunotherapy strategies in breast cancer.
    Page DB; Naidoo J; McArthur HL
    Immunotherapy; 2014; 6(2):195-209. PubMed ID: 24491092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer immunotherapy: Current and novel approaches.
    Barzaman K; Moradi-Kalbolandi S; Hosseinzadeh A; Kazemi MH; Khorramdelazad H; Safari E; Farahmand L
    Int Immunopharmacol; 2021 Sep; 98():107886. PubMed ID: 34153663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injecting Hope--A Review of Breast Cancer Vaccines.
    Mittendorf EA; Peoples GE
    Oncology (Williston Park); 2016 May; 30(5):475-81, 485. PubMed ID: 27188680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies.
    Cilibrasi C; Papanastasopoulos P; Samuels M; Giamas G
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines.
    Hashemzadeh N; Dolatkhah M; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y; Barar J
    Life Sci; 2021 Apr; 271():119110. PubMed ID: 33513401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for the treatment of breast cancer.
    Moreno Ayala MA; Gottardo MF; Asad AS; Zuccato C; Nicola A; Seilicovich A; Candolfi M
    Expert Opin Biol Ther; 2017 Jul; 17(7):797-812. PubMed ID: 28446053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for immunological approaches to breast cancer therapy.
    Monnot GC; Romero P
    Breast; 2018 Feb; 37():187-195. PubMed ID: 28629632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral approach to breast cancer immunotherapy.
    Arab A; Behravan N; Razazn A; Barati N; Mosaffa F; Nicastro J; Slavcev R; Behravan J
    J Cell Physiol; 2019 Feb; 234(2):1257-1267. PubMed ID: 30146692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.